5th Novel Conjugates Summit 2026

The 5th Novel Conjugates Summit is the industry’s only dedicated meeting for a comprehensive 3-day view into ‘what’s next beyond ADCs’, including which novel approaches are currently being explored, the scientific rationale behind each approach and how different targeting formats, linkers and payloads synergise to optimize the therapeutic index.

Whether your goal is to benchmark your pipeline, put your payload/format in the limelight, explore collaborations with complementary modalities, or stay ahead of fast-moving design trends, this summit offers a front-row seat to the next wave of conjugate innovation.

Hear directly from pharma search & evaluation teams and leading investors on what drives strategic interest in novel conjugate platforms, and how emerging biotechs can position themselves for collaboration or acquisition.